These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3615775)

  • 1. An objective measure of methylphenidate response: clinical use of the MCA.
    Greenberg LM
    Psychopharmacol Bull; 1987; 23(2):279-82. PubMed ID: 3615775
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
    Miller LG; Kraft IA
    Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning.
    Brown RT; Wynne ME; Slimmer LW
    J Clin Psychiatry; 1984 Nov; 45(11):473-6. PubMed ID: 6386794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adults and adolescents with attention deficit disorder: clinical and behavioral responses to psychostimulants.
    Yellin AM; Hopwood JH; Greenberg LM
    J Clin Psychopharmacol; 1982 Apr; 2(2):133-6. PubMed ID: 7076878
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained attention in boys with attention deficit disorder and the effect of methylphenidate.
    Brown RT; Wynne ME
    Pediatr Nurs; 1984; 10(1):35-9. PubMed ID: 6560384
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate.
    Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Camfferman G; Buitelaar JK; Koelega HS
    Psychophysiology; 2000 May; 37(3):334-46. PubMed ID: 10860411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate in children with minimal brain dysfunction: effects on attention span, visual-motor skills, and behavior.
    Seger EY; Hallum G
    Curr Ther Res Clin Exp; 1974 Jun; 16(6):635-41. PubMed ID: 4211145
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of methylphenidate for attention deficit hyperactivity disorder.
    Brostë SM
    CMAJ; 1990 Nov; 143(10):995, 998. PubMed ID: 2073256
    [No Abstract]   [Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I; Türkbay T; Cöngöloğlu A
    Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate compared with behavioral self-control in attention deficit disorder: preliminary report.
    Anderson EE; Clement PW; Oettinger L
    J Dev Behav Pediatr; 1981 Dec; 2(4):137-41. PubMed ID: 7320203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 17. Raising children in an age of Ritalin.
    O'Sullivan R
    J Androl; 2005; 26(3):302-3. PubMed ID: 15866993
    [No Abstract]   [Full Text] [Related]  

  • 18. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder.
    Sebrechts MM; Shaywitz SE; Shaywitz BA; Jatlow P; Anderson GM; Cohen DJ
    Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder.
    Hawk LW; Yartz AR; Pelham WE; Lock TM
    Psychopharmacology (Berl); 2003 Jan; 165(2):118-27. PubMed ID: 12417963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.